Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU742
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,368
Award facts
- Contract value 100% obligated
- $11,367.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,367.98 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Beyfortus 50 mg/0.5 ml syringes. This firm fixed-price delivery order, with an ultimate completion date of December 16, 2025, represents a non-set-aside competitive award for pharmaceutical delivery. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency and Medical Supply Chain demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains, from specialty medications and vaccines to medical devices and supplies. The SPE2DX contract vehicle enables the company to supply pharmaceutical products to support defense health operations globally, serving customers including the Defense Health Agency and the U.S. Coast Guard. This delivery order for Beyfortus, a respiratory syncytial virus immunoglobulin product, reflects continued federal investment in immunological therapeutics for military healthcare readiness.
Quick answers
Who was awarded contract SPE2DR26FU742?
SPE2DR26FU742 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FU742 worth?
The government has obligated $11,368 on SPE2DR26FU742.
Is contract SPE2DR26FU742 an order under another contract?
Yes. SPE2DR26FU742 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU742 competed?
The extent of competition for SPE2DR26FU742 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award